Last reviewed · How we verify
Multi-center, Open Label, Long-term Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant.
Details
| Lead sponsor | Cephalon |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 300 |
| Start date | 2004-04 |
| Completion | 2006-11 |
Conditions
- Pain
- Cancer
Interventions
- OraVescent fentanyl citrate
Primary outcomes
- Tolerability and safety of OraVescent fentanyl when used long-term
Countries
United States